Stage III Breast Cancer Recruiting Phase 2 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0031775 (Stage III Breast Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01750073Paclitaxel and Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Patients With Previously Untreated Breast CancerTreatment
NCT03179904FASN Inhibitor TVB-2640, Paclitaxel, and Trastuzumab in Treating Patients With HER2 Positive Advanced Breast CancerTreatment